Search Results 81-90 of 8012 for TNF

  1. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression - Mayo Clinic

    TNF-inhibitors; Methotrexate; IL-1Ra antagonist. Women who are pregnant or nursing; Elect not to provide peripheral blood draw. Cohort 2: History of ipsilateral ...

  2. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

    ... TNF-α apoptotic pathway, 2)alternative splicing, tipping the balance towards pro-apoptotic as opposed to anti-apoptotic isoforms, and 3)inhibition of the ...

  3. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Adipose tissue is not biologically inert, but rather is responsible for producing a myriad of cytokines, including TNF-alpha, one of the main inflammatory ...

  4. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  5. A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients - Mayo Clinic

    ... tumor necrosis factor receptor antagonist in adults with a clinical diagnosis of rheumatoid arthritis. Participation eligibility. Participant eligibility ...

  6. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

    Anti-TNF monotherapy;; anti-TNF combination therapy;; tofacitinib;; current use of systemic corticosteroids. Exclusion Criteria: Previously received COVID 19 ...

  7. Canakinumab (subcutaneous route) - Mayo Clinic

    CAPS is a rare, inherited disease of the immune system. Canakinumab injection is also used to treat tumor necrosis factor receptor associated periodic syndrome ...

  8. Valley fever - Symptoms & causes - Mayo Clinic

    People with certain autoimmune diseases, such as rheumatoid arthritis or Crohn's disease, who are being treated with anti-tumor necrosis factor (TNF) drugs also ...

  9. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    ... Tumor Necrosis Factor Therapy. Dig Dis Sci. 2023 Sep; 68 (9):3557-3561 ... Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep ...

  10. Phase 1 Crohn's Pediatric Sub-study of MSC AFP - Mayo Clinic

    Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted. All patients should have ...